Committee (IACUC) in the local interpretation and application of the law. is responsible for establishing guidelines and policies regulating animal use. reviewing protocols with surgical components. anesthesia/analgesia selection, and post-operative care and analgesia.
AYou will receive treatment with OPDIVO in a hospital or clinic, under the supervision of an experienced doctor. OPDIVO will be given to you as an infusion (a drip) into a vein (intravenously) over a period of 60 minutes, every 2 weeks.
1 OPDIVO 1 mg/kg with ipilimumab 3 mg/kg every 3 weeks for 4 doses followed by OPDIVO 3 mg/kg as a single agent every 2 weeks (OPDIVO plus ipilimumab arm; n=313), 2  OPDIVO 3 mg/kg every 2 weeks (OPDIVO arm; n=313), or.  Ipilimumab 3 mg/kg every 3 weeks for up to 4 doses (ipilimumab arm; n=311).